 |
|
Infectious Scleritis After Use of Immunomodulators
Arch Ophthalmol. 2002;120:1093-1094.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Infectious scleritis, typically occurring in eyes having predisposing
risk factors, is vision-threatening. We present a case of infectious scleritis
after chemotherapy, which, to our knowledge, has not been previously reported
as a risk factor.
Report of a Case
A 58-year-old woman manifested symptoms of a red, painful right eye
for 1 day. Four months previously, she had undergone right mastectomy for
breast cancer and was receiving chemotherapy with cyclophosphamide and epidoxorubicin.
She had completed the fifth course of chemotherapy 3 weeks before this visit.
Her medical history, including surgery and trauma, was otherwise unremarkable.
At presentation, slitlamp examination showed conjunctival congestion
with a 2 x 2-mm scleral nodule surrounded by episcleral vessels (Figure 1A). Other ocular findings were unremarkable.
Infectious scleritis was suspected. She was placed on a regimen of fortified
topical cefazolin sodium (25 mg/mL) and gentamicin sulfate (14 mg/mL) every
hour and systemic gentamicin sulfate, (60 mg) every 8 hours. . . . [Full Text of this Article]
Comment
Corresponding author and reprints: Ching-Hsi Hsiao, MD, Department
of Ophthalmology, Chang Gung Memorial Hospital, No. 199, Tung Hwa North Road,
Taipei 105, Taiwan, Republic of China (e-mail: qq_hsiao@yahoo.com).
|
